These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36815053)

  • 1. All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.
    Luo Z; Wu S; Zhou J; Xu W; Xu Q; Lu L; Xie C; Liu Y; Lu W
    Acta Pharm Sin B; 2023 Jan; 13(1):359-371. PubMed ID: 36815053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy.
    Luo Z; Lu L; Xu W; Meng N; Wu S; Zhou J; Xu Q; Xie C; Liu Y; Lu W
    J Control Release; 2022 Jun; 346():32-42. PubMed ID: 35378211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
    Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY
    Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis.
    Cavaco M; Pérez-Peinado C; Valle J; Silva RDM; Gano L; Correia JDG; Andreu D; Castanho MARB; Neves V
    Biomed Pharmacother; 2024 May; 174():116573. PubMed ID: 38613996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
    Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
    Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets.
    Lv Y; Ma X; Du Y; Feng J
    Onco Targets Ther; 2021; 14():589-607. PubMed ID: 33519208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options.
    Nakhjavani M; Samarasinghe RM; Shigdar S
    Drug Discov Today; 2022 May; 27(5):1298-1314. PubMed ID: 35101641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
    Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
    Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
    Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
    Malin D; Strekalova E; Petrovic V; Deal AM; Al Ahmad A; Adamo B; Miller CR; Ugolkov A; Livasy C; Fritchie K; Hamilton E; Blackwell K; Geradts J; Ewend M; Carey L; Shusta EV; Anders CK; Cryns VL
    Clin Cancer Res; 2014 Jan; 20(1):56-67. PubMed ID: 24132917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
    Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions.
    Lee KL; Chen G; Chen TY; Kuo YC; Su YK
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase-2-Responsive Surface-Changeable Liposomes Decorated by Multifunctional Peptides to Overcome the Drug Resistance of Triple-Negative Breast Cancer through Enhanced Targeting and Penetrability.
    Liu C; Zhao Z; Gao R; Zhang X; Sun Y; Wu J; Liu J; Chen C
    ACS Biomater Sci Eng; 2022 Jul; 8(7):2979-2994. PubMed ID: 35666956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in non-metastatic triple-negative breast cancer.
    Karhade M; Hall C; Mishra P; Anderson A; Kuerer H; Bedrosian I; Krishnamurthy S; Lucci A
    Breast Cancer Res Treat; 2014 Sep; 147(2):325-33. PubMed ID: 25164970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
    Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
    Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
    J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.